Profile data is unavailable for this security.
About the company
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
- Revenue in USD (TTM)2.88bn
- Net income in USD524.90m
- Incorporated1923
- Employees10.60k
- LocationWest Pharmaceutical Services Inc530 Herman O. West DriveEXTON 19341United StatesUSA
- Phone+1 (610) 594-2900
- Fax+1 (800) 345-9800
- Websitehttps://www.westpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revvity Inc | 2.71bn | 197.34m | 15.37bn | 11.50k | 78.01 | 1.95 | 24.53 | 5.67 | 1.60 | 1.37 | 21.90 | 63.80 | 0.1959 | 2.89 | 4.42 | 235,499.60 | 1.43 | 4.76 | 1.59 | 5.39 | 55.26 | 57.19 | 7.29 | 15.34 | 1.98 | 6.89 | 0.3299 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Insulet Corp | 1.87bn | 395.30m | 16.55bn | 3.00k | 43.62 | 16.58 | 35.16 | 8.84 | 5.41 | 5.41 | 24.53 | 14.24 | 0.711 | 1.38 | 6.25 | 624,233.30 | 15.01 | 2.71 | 18.15 | 3.14 | 69.00 | 65.81 | 21.11 | 4.28 | 2.71 | 87.97 | 0.5833 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Avantor Inc | 6.83bn | 360.20m | 18.40bn | 14.50k | 51.10 | 3.38 | 24.17 | 2.70 | 0.5295 | 0.5295 | 10.03 | 8.00 | 0.530 | 5.37 | 5.82 | 470,731.00 | 2.80 | 2.97 | 3.17 | 3.35 | 33.71 | 33.44 | 5.28 | 5.06 | 1.05 | 3.07 | 0.4848 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Align Technology, Inc. | 3.94bn | 447.03m | 18.90bn | 21.61k | 42.91 | 5.03 | 32.20 | 4.79 | 5.90 | 5.90 | 52.03 | 50.31 | 0.641 | 4.16 | 4.09 | 182,455.40 | 7.27 | 16.34 | 10.96 | 24.14 | 69.82 | 71.72 | 11.34 | 23.16 | 1.06 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Hologic Inc | 3.99bn | 701.50m | 18.98bn | 6.99k | 27.89 | 3.83 | 18.77 | 4.76 | 2.93 | 2.93 | 16.59 | 21.33 | 0.4375 | 2.64 | 6.06 | 570,472.10 | 7.70 | 11.40 | 8.64 | 13.38 | 55.41 | 60.29 | 17.59 | 20.95 | 3.32 | 709.77 | 0.3408 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Waters Corp | 2.88bn | 595.69m | 19.79bn | 7.90k | 33.21 | 14.01 | 25.13 | 6.88 | 10.04 | 10.04 | 48.46 | 23.79 | 0.6394 | 2.19 | 4.41 | 364,118.20 | 13.24 | 19.77 | 16.04 | 25.29 | 59.68 | 58.45 | 20.71 | 23.38 | 1.42 | 8.74 | 0.5869 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Baxter International Inc | 15.00bn | -157.00m | 20.09bn | 60.00k | -- | 2.63 | 18.10 | 1.34 | -0.3066 | 4.87 | 29.48 | 14.98 | 0.5534 | 3.24 | 5.73 | 249,950.00 | -0.5462 | 0.1942 | -0.7019 | 0.2333 | 36.48 | 38.20 | -0.9869 | 0.3674 | 0.9147 | 4.25 | 0.626 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Illumina Inc | 4.43bn | -3.04bn | 20.86bn | 10.59k | -- | 14.50 | -- | 4.71 | -19.18 | -19.18 | 27.94 | 9.03 | 0.4961 | 2.86 | 6.26 | 418,224.80 | -34.09 | -6.20 | -45.61 | -7.28 | 62.00 | 66.39 | -68.71 | -15.48 | 0.8596 | 14.07 | 0.6087 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| Zimmer Biomet Holdings Inc | 7.52bn | 997.10m | 21.64bn | 18.00k | 22.15 | 1.71 | 11.03 | 2.88 | 4.80 | 4.80 | 36.22 | 62.18 | 0.3515 | 0.9141 | 5.40 | 418,050.00 | 4.66 | 2.21 | 5.40 | 2.52 | 71.78 | 71.25 | 13.27 | 7.28 | 0.629 | 7.51 | 0.314 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Cooper Companies Inc | 3.80bn | 359.30m | 22.01bn | 15.00k | 61.55 | 2.78 | 29.90 | 5.79 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| West Pharmaceutical Services Inc. | 2.88bn | 524.90m | 22.43bn | 10.60k | 43.93 | 8.71 | 34.23 | 7.80 | 7.04 | 7.04 | 38.62 | 35.49 | 0.8037 | 4.26 | 5.68 | 271,405.70 | 14.22 | 15.61 | 16.93 | 18.65 | 35.69 | 38.06 | 17.70 | 18.47 | 1.68 | -- | 0.0751 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Steris PLC | 5.13bn | 567.70m | 23.51bn | 18.18k | 41.66 | 3.71 | 21.19 | 4.58 | 5.72 | 4.03 | 51.73 | 64.32 | 0.4914 | 3.98 | 5.77 | 282,395.10 | 5.45 | 5.19 | 5.95 | 5.68 | 43.19 | 43.64 | 11.09 | 10.97 | 1.49 | 7.03 | 0.2666 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
| DexCom Inc | 3.93bn | 666.90m | 27.83bn | 9.60k | 43.61 | 11.43 | 31.91 | 7.07 | 1.59 | 1.59 | 9.38 | 6.08 | 0.5778 | 2.92 | 4.64 | 409,875.00 | 9.79 | 8.30 | 13.57 | 10.50 | 63.16 | 65.90 | 16.95 | 14.14 | 2.48 | -- | 0.5063 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
| Mettler-Toledo International Inc | 3.75bn | 785.75m | 29.76bn | 16.00k | 38.60 | -- | 32.77 | 7.94 | 36.34 | 36.34 | 173.40 | -7.20 | 1.13 | 4.01 | 5.85 | 234,384.60 | 23.74 | 23.32 | 36.29 | 34.02 | 59.33 | 58.58 | 20.95 | 20.51 | 0.6337 | 13.58 | 1.08 | 0.00 | -3.35 | 5.23 | -9.60 | 8.85 | -5.90 | -- |
Data as of Sep 19 2024. Currency figures normalised to West Pharmaceutical Services Inc's reporting currency: US Dollar USD
43.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 8.62m | 11.89% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 4.19m | 5.78% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 3.20m | 4.42% |
| Walter Scott & Partners Ltd.as of 30 Jun 2024 | 2.77m | 3.83% |
| Artisan Partners LPas of 30 Jun 2024 | 2.49m | 3.44% |
| Franklin Advisers, Inc.as of 30 Jun 2024 | 2.44m | 3.36% |
| APG Asset Management NVas of 30 Jun 2024 | 2.33m | 3.22% |
| AllianceBernstein LPas of 30 Jun 2024 | 2.23m | 3.07% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.73m | 2.38% |
| Brown Advisory LLCas of 30 Jun 2024 | 1.70m | 2.34% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
